Company will invest approximately ¥16 billion to increase production capacity by approximately 70% to ensure a stable supply
The safety profile of KEYTRUDA plus LENVIMA was consistent with previously reported data on the combination.
Strides is the first Indian company to get approval for the product.
Under the PMBJP, till 30.06.2022, 8742 PMBJKs have been opened across the country including Government Hospitals and Government premises.
The two generic drugs have been launched under the brand names Jankey & Sitenali.
The facility is designed with advanced analytical equipment to provide testing services such as In-vitro Permeation testing
Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments
Subscribe To Our Newsletter & Stay Updated
